Table 1.

Vaccine formulations for allergen-specific immunotherapy.

Formulation	Antigen concentration per 100 µL (dose) of vaccine, µg*	Concentration/volume of adjuvant per 100 µL (dose) of vaccine	Method of administration
ISA-51 High dose	2, 4, 8, 16	50 µL	s/c
ISA-51 Low dose	0.2, 0.4, 0.8, 1.6	50 µL	s/c
SWE-CpG High dose	2, 4, 8, 16	50 µL (SWE) + 10 µg (CpG)	i/m
SWE-CpG Low dose	0.2, 0.4, 0.8, 1.6	50 µL (SWE) + 10 µg (CpG)	i/m

* Antigen concentrations for 1^st, 2^nd, 3^rd, and 4^th immunizations, respectively; s/c – subcutaneous; i/m – intramuscular.